Overview
BIAF market data
Price History
BIAF price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for BIAF. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
bioAffinity, Pictor Collaborate To Integrate Flow Cytometry And Proteomic Analysis Platform To Analyze Immune Cell Populations And Cytokine Profiles Related To Airway InflammationBenzinga · Jul 22, 2026, 12:11 PM
BioAffinity Technologies Announces 200% Sales Growth YoY For CyPath Lung Cancer DiagnosticBenzinga · Jul 7, 2026, 12:55 PM
bioAffinity To Present Preclinical Findings For Therapeutic Approach That Uses siRNAs That Kill Squamous And Basal Skin Cancer Cells In Vitro At 2026 RNA Therapeutics SymposiumBenzinga · Jun 22, 2026, 12:10 PM
bioAffinity Technologies Prices $3.2M Offering Of 4M Shares (Or Pre-funded Warrants) At $0.80/Share ($0.793/Warrant)Benzinga · Jun 17, 2026, 1:30 PM
bioAffinity Receives Mexican Institute Of Industrial Property Allowance For A Patent Application Regarding Methods Of Predicting The Likelihood Of Lung Cancer Using Flow CytometryBenzinga · May 27, 2026, 12:07 PM